Cumberland Pharmaceuticals Inc.: 10-K filed 2012-03-07
What Cumberland Pharmaceuticals Inc. reported in its annual report filed 2012-03-07 (fiscal FY 2011): 37 published measures, 97 facts as tagged in accession 0001193125-12-101478.
This filing
- Form
- 10-K (annual report)
- Filed
- 2012-03-07
- Fiscal period
- fiscal FY 2011
- Accession
- 0001193125-12-101478 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cumberland Pharmaceuticals Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 95,518,316 | USD | |
| At 2010-12-31 | 92,054,054 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 12,683,047 | USD | |
| At 2010-12-31 | 14,338,579 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 82,928,817 | USD | |
| At 2010-12-31 | 77,777,680 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 70,599,146 | USD | |
| At 2010-12-31 | 65,893,970 | USD | |
| At 2009-12-31 | 78,701,682 | USD | |
| At 2008-12-31 | 11,829,551 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 5,657,856 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 2,456,680 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 3,091,415 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 8,722,147 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 346,662 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 404,970 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 257,502 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 577,159 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 601,802 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -3,579,200 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -12,385,732 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 67,179,504 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -437,771 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -768,642 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -712,343 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 12,656,662 | USD | |
| At 2010-12-31 | 6,998,806 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 20,342,913 | shares | 365 |
| 2010-01-01 to 2010-12-31 | 20,333,932 | shares | 365 |
| 2009-01-01 to 2009-12-31 | 14,199,479 | shares | 365 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 20,572,132 | shares | 365 |
| 2010-01-01 to 2010-12-31 | 21,058,577 | shares | 365 |
| 2009-01-01 to 2009-12-31 | 18,234,171 | shares | 365 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 0.28 | USD/shares | 365 |
| 2010-01-01 to 2010-12-31 | 0.12 | USD/shares | 365 |
| 2009-01-01 to 2009-12-31 | 0.22 | USD/shares | 365 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 0.28 | USD/shares | 365 |
| 2010-01-01 to 2010-12-31 | 0.12 | USD/shares | 365 |
| 2009-01-01 to 2009-12-31 | 0.17 | USD/shares | 365 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 4,080,204 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 2,851,420 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 2,024,192 | USD | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 1,119,339 | USD | |
| At 2010-12-31 | 1,220,010 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 9,849,487 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 6,501,747 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 5,776,635 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 87,308,067 | USD | |
| At 2010-12-31 | 81,038,842 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 353,497 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 1,423,523 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 772,927 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 6,599,948 | USD | |
| At 2010-12-31 | 9,227,620 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 1,513,548 | USD | |
| At 2010-12-31 | 2,124,654 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 7,023,064 | USD | |
| At 2010-12-31 | 7,427,223 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 7,082,890 | USD | |
| At 2010-12-31 | 5,145,494 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 4,247,440 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 4,846,791 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 27,295,808 | USD | 365 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 5,774,694 | USD | |
| At 2010-12-31 | 7,683,842 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 5,028,072 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 4,327,485 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 4,993,278 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 20,020,535 | shares | |
| At 2010-12-31 | 20,338,461 | shares |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 82,835,269 | USD | |
| At 2010-12-31 | 77,715,475 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 67,846 | USD | |
| At 2010-12-31 | 102,787 | USD |
Net deferred tax assets
Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 0 | USD | |
| At 2010-12-31 | 2,265,192 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 5,626,513 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 2,427,011 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 3,058,879 | USD | 365 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 9,197,955 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 7,990,222 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 7,643,070 | USD | 365 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 1,040,407 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 978,398 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 816,499 | USD | 365 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 655,302 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 686,911 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 686,904 | USD | 365 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 1,665,110 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -332,349 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -525,467 | USD | 365 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 1,937,396 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -1,031,091 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 3,047,238 | USD | 365 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -1,909,148 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 2,860,969 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 3,060,097 | USD | 365 |
Inspect the source
- Entity
- Cumberland Pharmaceuticals Inc. / CIK 0001087294
- Captured
- 2026-09-20T05:21:29.619Z
- SEC response SHA-256
b37ed2fef35db1cde0c40b2233eb97cf370fc96d41a5c7d61b6a5a76a296e4a0
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001087294.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))